ClinicalTrials.gov
public full text
Public Domain
The vBlocT2D Study
Overall aim: To demonstrate that weight loss through vBloc Therapy in combination with usual care will achieve better glycemic control for patients with obesity and type 2 diabetes than usual care alone. Duration: Participants will be asked to participate in a 12 month study that involves a baseline visit and research follow-up visits at 3, 6, 9, and 12 months. Sample Size: 60 participants will be enrolled in the study. Of these, 30 will be randomized to vBloc therapy and 30 will be randomized to usual care.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Glucosanol™ in Reducing Post-prandial Glucose Levels in Overweight Subjects#969062
- Lifestyle Program Focused on Nourishment, Well-Being, and Health Behaviors in Women With Obesity#1149992
- The Impact of CGM on Weight Reduction#848212
- Improving Glycemic Control Using a Virtual Weight Control Program Among Adults With Type 2 Diabetes#801059
- A Personalized Diet Study to Reduce Glycemic Exposure#1139998
Record · ID 1103871
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive